Paul Haste
Overview
Explore the profile of Paul Haste including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lam M, Garin E, Haste P, Denys A, Geller B, Kappadath S, et al.
Eur J Nucl Med Mol Imaging
. 2024 Sep;
52(2):744-755.
PMID: 39331131
Purpose: Pre-treatment [Tc]TcMAA-based radioembolization treatment planning using multicompartment dosimetry involves the definition of the tumor and normal tissue compartments and calculation of the prescribed absorbed doses. The aim was to...
2.
Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, et al.
J Natl Compr Canc Netw
. 2024 Aug;
22(6):366-375.
PMID: 39151454
The determination of an optimal treatment plan for an individual patient with rectal cancer is a complex process. In addition to decisions relating to the intent of rectal cancer surgery...
3.
Benson A, Venook A, Adam M, Chang G, Chen Y, Ciombor K, et al.
J Natl Compr Canc Netw
. 2024 Jun;
22(2 D).
PMID: 38862008
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active...
4.
Lam M, Garin E, Palard-Novello X, Mahvash A, Kappadath C, Haste P, et al.
Eur J Nucl Med Mol Imaging
. 2023 Sep;
51(1):245-257.
PMID: 37698645
Purpose: Investigate reproducibility of two segmentation methods for multicompartment dosimetry, including normal tissue absorbed dose (NTAD) and tumour absorbed dose (TAD), in hepatocellular carcinoma patients treated with yttrium-90 (Y) glass...
5.
Albertson N, Rice M, Schmitz A, Eskew J, Haste P, Johnson M
J Vasc Surg Venous Lymphat Disord
. 2022 Sep;
11(2):310-317.
PMID: 36179788
Objective: We sought to determine the clinical and imaging outcomes after placement of the OptionELITE inferior vena cava (IVC) filter (Argon Medical Devices, Plano, TX). Methods: The clinical characteristics and...
6.
Salem R, Padia S, Lam M, Chiesa C, Haste P, Sangro B, et al.
Eur J Nucl Med Mol Imaging
. 2022 Sep;
50(2):328-343.
PMID: 36114872
Purpose: In light of recently published clinical reports and trials, the TheraSphere Global Dosimetry Steering Committee (DSC) reconvened to review new data and to update previously published clinical and dosimetric...
7.
Lam M, Garin E, Maccauro M, Kappadath S, Sze D, Turkmen C, et al.
Eur J Nucl Med Mol Imaging
. 2022 Apr;
49(10):3340-3352.
PMID: 35394152
Purpose: To investigate the relationships between tumor absorbed dose (TAD) or normal tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) treated with yttrium-90 glass microspheres. Methods: TARGET...
8.
Rice M, Krosin M, Haste P
Semin Intervent Radiol
. 2021 Oct;
38(4):460-465.
PMID: 34629714
Transarterial radioembolization with yttrium-90 ( Y) is a mainstay for the treatment of liver cancer. Imaging the distribution following delivery is a concept that dates back to the 1960s. As...
9.
Schmitz A, Haste P, Johnson M
J Gastrointest Surg
. 2019 Sep;
24(10):2228-2232.
PMID: 31485902
Purpose: Transjugular intrahepatic portosystemic shunt (TIPS) creation is most commonly performed for patients with refractory ascites or variceal hemorrhage. While TIPS have also been created prior to planned abdominal operation...
10.
Wawira Gichoya J, Kohli M, Haste P, Abigail E, Johnson M
J Digit Imaging
. 2017 Jun;
30(5):602-608.
PMID: 28623557
Numerous initiatives are in place to support value based care in radiology including decision support using appropriateness criteria, quality metrics like radiation dose monitoring, and efforts to improve the quality...